Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Simbiosys
SimBioSys is a TechBio company focused on redefining precision medicine and revolutionizing patient care to defeat cancer. They leverage artificial intelligence, data science, and spatial biophysics…
Simbiosys
SimBioSys is a TechBio company focused on redefining precision medicine and revolutionizing patient care to defeat cancer. They leverage artificial intelligence, data science, and spatial biophysics…
TL;DR
HQ: Chicago, IL
Product: TumorSight — cloud-based digital precision medicine platform (TumorSight Viz is a surgical visualization app)
Clinical milestone: TumorSight Viz received FDA 510(k) clearance (announced Jan 2024)
Clinical focus: Breast cancer and solid-tumor surgical planning
Series A: $15M announced Oct 26, 2021 (co-led by Genoa Ventures and Northpond Ventures)
Company Overview
Problem Domain
Precision oncology — improving treatment planning and biomarker discovery for breast and other solid tumors
Founded
2018
Industry
Biotechnology
Funding Track Record
$15,000,000
Participation reported from AV8 Ventures, Heritage Medical Group, and Mayo Clinic; total capital reported to $21M after the round in company materials.
Investor Signal
“Participating investors include venture firms (Genoa Ventures, Northpond Ventures, AV8 Ventures, Heritage Medical Group) and Mayo Clinic as strategic collaborator/investor”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |